This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Jay A. Levy, MD

JAMA. 1988;259(20):3037-3038.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CURRENT approaches to preventing infection with the human immunodeficiency virus (HIV) have focused on the retrovirus itself. However, biologic and epidemiologic studies of HIV and the acquired immunodeficiency syndrome (AIDS) indicate that more emphasis should be placed on the virus-infected cell. Several groups of researchers^1-10 have demonstrated the presence of HIV in many different hematopoietic cells, including T and B lymphocytes and macrophages, as

See also p 3023. well as in cells (macrophages and endothelial and glial cells) of the brain. These infected cells can survive and serve as reservoirs (factories) for continual virus production and spread. When found in body fluids, they can transfer the infection to other individuals. T-helper lymphocytes generally die after HIV infection,^1-4 but some can replicate HIV to high titer in culture without undergoing cell death.¹¹ Thus, they too could serve as a source of virus transmission.

In studies from our laboratory, . . . [Full Text PDF of this Article]

Author Affiliations
From the Cancer Research Institute, Department of Medicine, University of California School of Medicine, San Francisco.

Footnotes
Reprint requests to the Cancer Research Institute, Department of Medicine, University of California School of Medicine, San Francisco, CA 94143-0128 (Dr Levy).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?